ESO-EONS Masterclass in Oncology Nursing

Chair: S. Faithfull, UK
Scientific Co-ordinators: D. Papageorgiou, GR and A. Margulies, CH


The Masterclass in Oncology Nursing programme is designed for advanced oncology nurses as a multi-professional joint event. Five intensive days of full immersion in up-to-date oncology will create a collective spirit of teaching and learning to improving clinical skills and patient care.

In joint Clinical sessions, nurses will, together with physicians, update their clinical knowledge about the latest issues for the management of breast, gynaecological, prostate, colorectal cancer and lung cancer, with an international faculty of experts. Special joint sessions in supportive care, communication skills and palliative care will be supported by workshops and coaching to explore nursing practice in these speciality areas.

Nursing sessions are specific nursing-oriented sessions exploring specialist practice skills such as advanced assessment, decision making, communication skills, complex symptom management, care of the older patient, psychosexual consequences of cancer therapy and long term adverse effects of cancer therapy and  managing advanced disease.

Practical training will be offered in smaller group optional sessions and coaching groups  focusing on skills required for the management of active therapy and follow up for example assessing psychological distress, managing sexual concerns raised by patients. Furthermore reviewing and understanding the growing evidence base for nursing interventions plus reflections on participant’s role in clinical leadership.


AIMS AND OBJECTIVES
The Masterclass aims to prepare oncology nurses for future senior roles and enhance their clinical skills in the management of the cancer patient journey. Following completion of the course nurses will be able to use evidence based knowledge in effective symptom management and interventions with the aim to improve patient experience, symptom management and care.

Learning outcomes:
• Understand new developments in oncology disease management.
• Recognise and describe acute and late adverse effects of cancer and its treatment.
• Reflect on theoretical underpinnings of decision making and differential diagnosis.
• Identify complex patient needs across the diagnostic and oncology treatment trajectory.
• Demonstrate advanced communication skills in managing oncology nursing care.
• Critically appraise the evidence for cancer symptom management and intervention.
• Describe the role of the advanced oncology nurse in leading clinical nursing care.


TEACHING FORMAT
The Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and which will include notes and resources. Participants will be coached within small groups and discuss personal development plans with tutors in the faculty. Skills based clinical sessions will include simulation and role play and participants must be prepared to join in.

All participants will reside at the course venue and participation is compulsory throughout the course.
The Masterclass will be entirely in English and fluency in English is necessary for admission.
Participants of the Masterclass in Nursing Oncology will attend selected medical sessions, depending on work speciality and requirements for study, whilst the advanced communication skills, palliative and supportive care sessions will be attended jointly.


THE MASTERCLASS IS:
• A 5-day residential educational event
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts delivering  advanced concepts

ORGANISING SECRETARIAT
eons.secretariat@cancernurse.eu
European Oncology Nursing Society, EONS Secretariat
Att. Rudi Brike
E. Mounierlaan 83
1200 Brussels, Belgium
Phone +32 2 779 9923, Fax +32 2 779 9937


ACCREDITATION
The Masterclass programme will be accredited by the European Oncology Nursing Society.

FACULTY
M. Aapro, IMO Clinique de Genolier, FMH Oncologie-Hématologie, Genolier, CH
M.R. Alison, Barts and the London School of Medicine and Dentistry, Institute of Cell and Molecular Science, Centre for Diabetes, London, UK
A. Arber, Faculty of Health and Medical Sciences, University of Surrey, Guilford, UK
R. Beets-Tan, Maastricht University Medical Center, Department of Radiology, Maastricht, NL
J. Bernhard, Berne University Hospital, Inselspital, Department of Medical Oncology, Berne, CH
J. Bernier, Genolier Swiss Medical Network, Department of Radiotherapy, Genolier, CH
G. Curigliano, European Institute of Oncology, Division of Medical Oncology, Milano, IT
A. Dietz, University of Leipzig, Department of Otolaryngology, Leipzig, DE
S. Faithfull, Faculty of Health and Medical Sciences, University of Surrey, Guilford, UK
C. Faivre-Finn, Christie Hospital NHS Foundation Trust, Department of Clinical Oncology, Manchester, UK
K. Fizazi, Institut Gustave Roussy, Department of Medicine, Villejuif, FR
E. Furlong, University College Dublin, Health Sciences Centre, Dublin, IR
A. Glaus, Tumor-Center ZETUP, Department of Medical Oncology, St. Gallen, CH
A. Goldhirsch, European Institute of Oncology, Department of Medicine, Milano, IT
B. Grube, University College Metropol, Head of Education for Advanced Cancer Nurses, Copenhagen, DK
A. Hoy, Consultant in Palliative Medicine, Lead for Advanced Communication Skills SWSH, Epsom, UK
K. Leonard, St. Luke’s Hospital, Advanced Practitioner in Oncology, Dublin, IR
A. Margulies, Clinical Oncology Nurse, EONS Executive Board Member, Zurich, CH
D. Papageorgiou, Euroclinic Athens, Oncology Unit, Athens, GR
T. Powles, Barts and the London NHS Trust, Department of Medical Oncology, London, UK
K. Redmond, Cancer World Editor, Lugano, CH
L. Repetto, INRCA,  Department of Geriatric Oncology, Rome, IT
P. Rougier, Georges Pompidou Hospital, Department of Digestive Oncology, Paris, FR
D. Schrijvers, Ziekenhuisnetwerk Antwerpen-Middelheim, Department of Haemato-Oncology, Antwerp, BE
D. Sebag-Montefiore, University of Leeds, Leeds Cancer Centre, Department of Clinical Oncology, Leeds, UK
E. Senkus-Konefka, Medical University of Gdansk, Department of Oncology and Radiotherapy, Gdansk, PL
C. Sessa, Oncology Institute of Southern Switzerland, Division of Medical Oncology, Bellinzona, CH
L. Sharp, Karolinska University Hospital, Section for Nursing, Stockholm, SE
R.A. Stahel, University Hospital Zurich, Clinic and Policlinic for Oncology, Zurich, CH
E. Van Cutsem, University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, BE
J.B. Vermorken, University Hospital Antwerp, Department of Oncology, Edegem, BE
W. Weder, University Hospital Zurich, Division of Thoracic Surgery, Zurich, CH

2 April

3 April

4 April

5 April

6 April

7 April